Abstract
In a classic on organizational culture and leadership, the distinguished professor of business management, Edgar Schein holds that “the only thing of real importance that leaders do is to create and manage culture … the source of the beliefs and values that get a group moving in dealing with its internal and external problems.”1
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
Schein E. Organizational Culture and Leadership. 4th ed. San Francisco: JosseyBass; 2010: 11, 36.
Lessig L. Institutional Corruptions. Cambridge, MA: Research in Action Working Papers, Edmond J. Safra Center for Ethics, Harvard University; 2013.
Angell M. The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House; 2004
Goldacre B. Bad Pharma: How Drug Companies Mislead Doctors and Harm. London: Faber & Faber; 2012
Healy D. Pharmageddon. Berkeley: University of California Press; 2012
Light DW. Reducing Global Health Disparities through Vaccines: Rhetorics and Realities of Advanced Market Commitments. Dean’s Colloquium, UC Berkeley School for Public Health. Berkeley, CA 2010 (4 Nov).
Leonardi A, Baggott J, Pantarotto C. The Mario Negri Institute for Pharmacological Research. Pharmacy International. 1980 (Sept): 170–173.
Wright E. Envisioning Real Utopias. New York: Verso; 2010.
Brody H. The commercialization of medical decisions: physicians and patients at risk. In: Light DW, ed. The Risks of Prescription Drugs. New York: Columbia University Press; 2010: 70–90
Stults C, Conrad P. Medicalization and Risk Scares: The Case of Menopause and HRT. In: Light DW, ed. The Risks of Prescription Drugs. New York: Columbia Unviersity Press; 2010: 116–139
NPR. How a bone disease grew to fit the prescription. 2009; file:///Users/dlight/Documents/Safra-PharmOsteopenia%20-new%20disease%20NPR.webarchive
Moynihan R, Cassels A. Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients. New York: Nation Books; 2005.
Garattini S. Fa bene o fa male? Salute, ricerca e farmaci: tutto quello che bisogna sapere (Is it healthy or not? Health, research and pharmaceuticals: all you need to know). Milano: Sperling & Kupfer; 2013.
Knorr-Cetina K. Epistemic Cultures: How the Sciences Make Knowledge. Cambridge, MA: Harvard University Press; 1999.
Hollister L, Garattini S. In: Silser F, ed. An Oral History of Neuropsychopharmacology Vol 3 Neuropharmacology. Brentwood, Tennessee: American College of Psychopharmacology 1995: 206.
Pfeffer J, Salancik G. The External Control of Organizations: A Resource Dependence Perspective. Stanford, CA: Stanford University Press; 2003: 1.
Christakis N, Fowler J. Connected: The Amazing Power of Social Networks and How They Shape Our Lives. New York: Harper Press; 2000.
Bessen J, Meurer M. Patent Failure: How Judges, Bureacrats and Lawyers Put Innovation at Risk. Princeton: Princeton University Press; 2008
Heller MA, Eisenberg RS. Can patents deter innovation? The anticommons in biomedical research. Science. 1998; 280 (5364): 698–701.
Copyright information
© 2015 Donald W. Light and Antonio F. Maturo
About this chapter
Cite this chapter
Light, D.W., Maturo, A.F. (2015). The Formative Years—Leadership, Culture, and Organization. In: Good Pharma. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137374332_3
Download citation
DOI: https://doi.org/10.1057/9781137374332_3
Publisher Name: Palgrave Macmillan, New York
Print ISBN: 978-1-349-67840-2
Online ISBN: 978-1-137-37433-2
eBook Packages: Palgrave Social Sciences CollectionSocial Sciences (R0)